MEDCO HEALTH SOLUTIONS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 35 rows in 2006. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2006-08-11: Reporting owner SMITH JACK ALLEN; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-08-10: Reporting owner KLEPPER KENNETH O; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-08-08: Reporting owner KLEPPER KENNETH O; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2006-07-24: Reporting owner KLEPPER KENNETH O; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2006-08-11 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 30,000 owned after | $26.92 exercise price | 2006-08-14 | |
| 2006-08-10 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,777 26,667 owned after | $32.51 exercise price | 2006-08-11 | |
| 2006-08-08 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,778 44,444 owned after | $32.51 exercise price | 2006-08-09 | |
| 2006-07-24 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,778 62,222 owned after | $32.51 exercise price | 2006-07-25 | |
| 2006-05-24 | WILSON BLENDA J Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $52.03 exercise price | 2006-05-25 | |
| 2006-05-24 | STROM BRIAN L Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $52.03 exercise price | 2006-05-25 | |
| 2006-05-24 | SHORTLIFFE EDWARD H Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $52.03 exercise price | 2006-05-25 | |
| 2006-05-24 | LILLIS CHARLES M Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $52.03 exercise price | 2006-05-25 | |
| 2006-05-24 | LEWIN LAWRENCE S Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $52.03 exercise price | 2006-05-25 | |
| 2006-05-24 | GOLDSTEIN MICHAEL Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $52.03 exercise price | 2006-05-25 | |
| 2006-05-24 | CASSIS JOHN L Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $52.03 exercise price | 2006-05-25 | |
| 2006-05-24 | BARKER HOWARD W JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,000 8,000 owned after | $52.03 exercise price | 2006-05-25 | |
| 2006-03-24 | NARDIN ARTHUR H Officer (SVP, Pharma Contracting) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 0 owned after | $26.92 exercise price | 2006-03-27 | |
| 2006-03-24 | NARDIN ARTHUR H Officer (SVP, Pharma Contracting) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 20,000 owned after | $32.51 exercise price | 2006-03-27 | |
| 2006-03-10 | WENTWORTH TIMOTHY C Officer (President & CEO - Accredo) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 0 owned after | $26.92 exercise price | 2006-03-13 | |
| 2006-03-10 | WENTWORTH TIMOTHY C Officer (President & CEO - Accredo) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,333 17,334 owned after | $32.51 exercise price | 2006-03-13 | |
| 2006-03-03 | WENTWORTH TIMOTHY C Officer (President & CEO - Accredo) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,480 33,480 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | TAYLOR GLENN C Officer (Group President, Key Accounts) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,480 24,480 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | SNOW DAVID B JR Director, Officer (Chairman and CEO & Dir.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +185,000 185,000 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | RUBINO RICHARD J Officer (SVP & Controller) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,080 10,080 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | REED JOANN A Officer (SVP, Finance and CFO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,480 24,480 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | NARDIN ARTHUR H Officer (SVP, Pharma Contracting) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,600 21,600 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | MACHLOWITZ DAVID Officer (SVP, General Counsel & Secy.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,600 21,600 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +61,200 61,200 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | GRIFFIN BRIAN T Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,480 24,480 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | EPSTEIN ROBERT S Officer (SVP Medical Affairs & CMO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | DRISCOLL JOHN PATRICK Officer (SVP Product & Bus. Development) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,480 24,480 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | BIRCH BRYAN D Officer (President, Employer Accounts) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,480 24,480 owned after | $58.48 exercise price | 2006-03-07 | |
| 2006-03-03 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,667 0 owned after | $26.92 exercise price | 2006-03-06 | |
| 2006-03-03 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,333 17,334 owned after | $32.51 exercise price | 2006-03-06 | |
| 2006-03-01 | TAYLOR GLENN C Officer (Group President, Key Accounts) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,667 0 owned after | $26.92 exercise price | 2006-03-02 | |
| 2006-03-01 | EPSTEIN ROBERT S Officer (SVP Medical Affairs & CMO) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −75,034 0 owned after | $26.92 exercise price | 2006-03-02 | |
| 2006-03-01 | BIRCH BRYAN D Officer (Group President, Systemed) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 30,000 owned after | $32.51 exercise price | 2006-03-02 |